Skip to content

Study · Not a test of the peptide alone · 2016

2 results

Homeopathic treatments modify inflammation but not behavioral response to influenza antigen challenge in BALB/c mice.

Siqueira CM, Motta PD, Cardoso TN, de Paula Coelho C, Popi AF, Couceiro JN, Bonamin LV, Holandino C

Homeopathy : the journal of the Faculty of Homeopathy4 May 2016Cited by 5 (Europe PMC)

PMID27473547 (opens in a new tab)DOI10.1016/j.homp.2016.04.002 (opens in a new tab)PepBankPUB-27473547
Publisher pagePubMedAsk about this study
Jump to 2 results

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study2

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone2

In this study, Thymulin (serum thymic factor) was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Thymulin (serum thymic factor).

  1. 01AnimalNot a test of Thymulin (serum thymic factor) aloneAnimal study (in vivo)Efficacy outcome

    In BALB/c mice, homeopathic thymulin treatment produced no open-field behavioral changes at any tested time point.

    In plain wordsIn mice, the homeopathic thymulin preparation produced no behavioral changes in open-field tests.

    Peptide
    Thymulin (serum thymic factor)
    Outcome
    No significant changeOpen-field behavior
    Study

    mousen: not reported in source

    BALB/c mice challenged with influenza antigen
    Outcome group
    Locomotor and behavioral activity · Nervous system and cognition

    Source sentences

    Summary
    No behavioral changes were seen in OF tests at any time point after treatments.
    3 context sentences
    Summary · context
    Male adult mice were treated orally and blindly for 21 days with highly diluted influenza virus or with thymulin, and were divided in two sets of experiments.
    Summary · context
    In the second series, mice were challenged subcutaneously with influenza hemagglutinin antigen (7 μg/200 μl) at day 21.
    Summary · context
    At day 42, behavior and inflammation response were evaluated.

    In this study, Thymulin (serum thymic factor) was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Thymulin (serum thymic factor).

  2. 02AnimalNot a test of Thymulin (serum thymic factor) aloneAnimal study (in vivo)Mechanism

    In BALB/c mice, T and B cell balance changed significantly after influenza antigen challenge, with changes varying by homeopathic treatment.

    In plain wordsIn mice, immune-cell balance changed after influenza antigen challenge, and changes varied by homeopathic treatment.

    Peptide
    Thymulin (serum thymic factor)
    Outcome
    MixedT and B cell balance after antigen challenge
    Study

    mousen: not reported in source

    BALB/c mice challenged with influenza antigen
    Outcome group
    Immune response · Immune and inflammation

    Source sentences

    Summary
    Flow cytometry and morphometry revealed significant changes in T and B cell balance after influenza antigen challenge, varying according to treatment.
    3 context sentences
    Summary · context
    Male adult mice were treated orally and blindly for 21 days with highly diluted influenza virus or with thymulin, and were divided in two sets of experiments.
    Summary · context
    In the second series, mice were challenged subcutaneously with influenza hemagglutinin antigen (7 μg/200 μl) at day 21.
    Summary · context
    At day 42, behavior and inflammation response were evaluated.

    In this study, Thymulin (serum thymic factor) was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Thymulin (serum thymic factor).

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 3Current

    21 Oct 2026, 15:58 UTC

    Study results updated

  2. Version 2

    21 Oct 2026, 13:55 UTC

    Study data updated · source update from Europe PMC

  3. Version 1

    21 Oct 2026, 12:50 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.